Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Medizinische Klinik|October 14, 1977
[Clinical course and pathogenesis of oral contraceptive hypertension (author's transl)]J Girndt, F SchelerKlinische Wochenschrift|April 1, 1977
[The pathogenesis of oral contraceptive hypertension (author's transl)]J Girndt, F SchelerKlinische Wochenschrift|April 1, 1977
[The influence of the beta-blocking agent pindolol on blood pressure and heart weight of rats with Goldblatt-type hypertension (author's transl)]J Girndt, A Kramer, F SchelerDeutsche Medizinische Wochenschrift (1946)|February 3, 1978
[Are clotting disorders a pathogenetic factor in nephrosclerosis and hypertension? (author's transl)]J Girndt, F Scheler, A BohleDeutsche Medizinische Wochenschrift (1946)|November 14, 1980
[Oestrogen as a risk factor for the vascular system (author's transl)]J Girndt, Z Calkanis, H Kreuzer, et al.Deutsche Medizinische Wochenschrift (1946)|August 20, 1976
[Oral contraceptives, hypertension and nephrosclerosis (author's transl)]J Girndt, P Kramer, E Quellhorst, et al.British Medical Journal|December 22, 1973
Use of Tenckhoff catheter for peritoneal dialysis in terminal renal failureP G Lankisch, H J Tönnis, E Fernandez-Redo, et al.Fortschritte Der Medizin|February 16, 1978
[Oral contraceptives, hypertension and nephrosclerosis]J GirndtKlinische Wochenschrift|August 1, 1979
[High dose betablocker treatment in experimental renal hypertension (author's transl)]J GirndtPageof 13